Nomograms predict overall survival for patients with small-cell lung cancer incorporating pretreatment peripheral blood markers

Journal of Thoracic Oncology

Volumn 10, Issue 8, 2015, Pages 1213-1220

  Xie, Dong ^a,b   Marks, Randolph ^c   Zhang, Mingrui ^b   Jiang, Gening ^a   Jatoi, Aminah ^c   Garces, Yolanda I ^d   Mansfield, Aaron ^c   Molina, Julian ^c   Yang, Ping ^b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Mayo Clinic College of Medicine   (United States)

^c Division of Medical Oncology   (United States)

^d MAYO CLINIC   (United States)

Author keywords

Hematological markers.; Neutrophil to lymphocyte ratio; Nomogram; Prediction model; Small cell lung cancer; Survival

Indexed keywords

BIOLOGICAL MARKER; HEMOGLOBIN; ANTINEOPLASTIC AGENT; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CLINICAL STUDY; ELECTRONIC MEDICAL RECORD; ERYTHROCYTE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEUTROPHIL LYMPHOCYTE RATIO; NOMOGRAM; OVERALL SURVIVAL; PLATELET LYMPHOCYTE RATIO; PREDICTION; PREMEDICATION; PRIORITY JOURNAL; SMALL CELL LUNG CANCER; BLOOD; CANCER STAGING; HEALTH STATUS; LUNG NEOPLASMS; LYMPHOCYTE COUNT; MEAN CORPUSCULAR VOLUME; METABOLISM; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RADIOTHERAPY; SECONDARY; SKULL IRRADIATION; SMALL CELL LUNG CARCINOMA; SMOKING CESSATION; THROMBOCYTE COUNT; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BIOMARKERS, TUMOR; CRANIAL IRRADIATION; ERYTHROCYTE INDICES; FEMALE; HEALTH STATUS; HEMOGLOBINS; HUMANS; LUNG NEOPLASMS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUTROPHILS; NOMOGRAMS; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY; SMALL CELL LUNG CARCINOMA; SMOKING CESSATION;

EID: 84942905355     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000585     Document Type: Article

References (22)

1. Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006;24:4539-4544.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
3. Maestu I, Pastor M, Gmez-Codina J, et al. Pretreatment prognostic factors for survival in small-cell lung cancer: A new prognostic index and validation of three known prognostic indices on 341 patients. Ann Oncol 1997;8:547-553.
4. Cerny T, Blair V, Anderson H, Bramwell V, Thatcher N. Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients. Int J Cancer 1987;39:146-149.
5. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454:436-444.
6. Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg 2009;137:425-428.
7. Forget P, Machiels JP, Coulie PG, et al. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery. Ann Surg Oncol 2013;20(Suppl 3):S650-S660.
8. Lee S, Oh SY, Kim SH, et al. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer 2013;13:350.
9. Warwick R, Mediratta N, Shackcloth M, Shaw M, McShane J, Poullis M. Preoperative red cell distribution width in patients undergoing pulmonary resections for non-small-cell lung cancer. Eur J Cardiothorac Surg 2014;45:108-113.
10. Koma Y, Onishi A, Matsuoka H, et al. Increased red blood cell distribution width associates with cancer stage and prognosis in patients with lung cancer. PLoS One 2013;8:e80240.
11. Yang P, Allen MS, Aubry MC, et al. Clinical features of 5,628 primary lung cancer patients: Experience at Mayo Clinic from 1997 to 2003. Chest 2005;128:452-462.
12. Stotz M, Gerger A, Eisner F, et al. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer 2013;109:416-421.
13. Contala C, OQuigley J. An application of changepoint methods in studying the effect of age on survival in breast cancer. Comput Stat Data Anal 1999;30:253-270.
14. Nathan SD, Reffett T, Brown AW, et al. The red cell distribution width as a prognostic indicator in idiopathic pulmonary fibrosis. Chest 2013;143:1692-1698.
15. Colinet B, Jacot W, Bertrand D, et al.; oncoLR health network. A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: Description and comparison with the Charlsons index. Br J Cancer 2005;93:1098-1105.
16. Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 2008;26:1364-1370.
17. Teramukai S, Kitano T, Kishida Y, et al. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer 2009;45:1950-1958.
18. Kobayashi N, Usui S, Kikuchi S, et al. Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer. Lung Cancer 2012;75:223-227.
19. Aoe K, Hiraki A, Ueoka H, et al. Thrombocytosis as a useful prognostic indicator in patients with lung cancer. Respiration 2004;71:170-173.
20. Foster NR, Mandrekar SJ, Schild SE, et al. Prognostic factors differ by tumor stage for small cell lung cancer: A pooled analysis of North Central Cancer Treatment Group trials. Cancer 2009;115:2721-2731.
21. Socinski MA, Bogart JA. Limited-stage small-cell lung cancer: The current status of combined-modality therapy. J Clin Oncol 2007;25:4137-4145.
22. Vallires E, Shepherd FA, Crowley J et al.; International Association for the Study of Lung Cancer International Staging Committee and Participating Institutions. The IASLC Lung Cancer Staging Project: Proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2009;4:1049-1059.